You are viewing: Rest Of Europe Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The Rest Of Europe Empty Capsules Market was valued at $132.3 Million in 2025 and projected to reach to $162.3 Million by 2030, representing a compound annual growth rate of 4.2%. Rest Of Europe's empty capsules market is positioned for sustained expansion, supported by the region's established pharmaceutical manufacturing ecosystem and growing adoption of capsule-based formulations.

Rest Of Europe Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Empty Capsules Market Trends and Insights

  • The region is projected to expand to $162.3 million by 2030, representing a compound annual growth rate of 4.2%.
  • Rest Of Europe benefits from a robust pharmaceutical manufacturing base and increasing demand for capsule-based formulations across multiple therapeutic categories.
  • The market in Rest Of Europe is driven by rising pharmaceutical production, growing preference for capsule dosage forms, and expanding nutraceutical applications.
  • Rest Of Europe's growth trajectory reflects broader European healthcare trends, including regulatory support for pharmaceutical innovation and investment in manufacturing infrastructure.
  • By 2030, Rest Of Europe is expected to maintain its position as a significant contributor to the European empty capsules market, supported by continued pharmaceutical development and evolving consumer health preferences..

Key Market Statistics

  • CAGR (2025-2030) 4.2% CAGR
  • Market Size, 2025 ~USD 132.3 Million
  • Forecast, 2030 ~USD 162.3 Million
  • Country Rest Of Europe

Rest Of Europe Empty Capsules Market Overview

Steady Regional Growth :

Rest Of Europe's empty capsules market is projected to grow from $132.3 million in 2025 to $162.3 million by 2030, driven by increasing pharmaceutical manufacturing activities and rising demand for capsule-based drug delivery systems across the region.

Robust Pharmaceutical Base :

The region benefits from a well-established pharmaceutical manufacturing infrastructure, with numerous contract manufacturers and generic drug producers relying on empty capsules for various therapeutic formulations and nutraceutical applications.

Therapeutic Diversification :

Rest Of Europe's market is expanding across multiple therapeutic categories including cardiovascular, respiratory, gastrointestinal, and dietary supplement segments, reflecting diverse healthcare needs and consumer preferences across different European markets.

Moderate CAGR Performance :

With a 4.2% CAGR through 2030, Rest Of Europe demonstrates consistent but measured growth compared to the global market's 5.6% CAGR, indicating stable demand and mature market dynamics in the region.

Rest Of Europe Empty Capsules Market Dynamics

  • The market's 4.2% CAGR reflects steady demand from both pharmaceutical manufacturers and nutraceutical producers seeking reliable capsule suppliers for diverse therapeutic applications. Key growth drivers include increasing generic drug production, rising consumer preference for capsule formulations, and regulatory support for pharmaceutical manufacturing within the region.
  • As healthcare spending remains robust across Rest Of Europe, manufacturers are expected to continue investing in capsule-based delivery systems, supporting market expansion through 2030..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Rest Of Europe's empty capsules market is valued at $132.3 million in 2025 and is forecast to grow to $162.3 million by 2030.
    • Rest Of Europe is experiencing a 4.2% CAGR, reflecting steady demand from pharmaceutical and nutraceutical manufacturers.
    • Rest Of Europe's market growth is supported by strong regulatory frameworks and established pharmaceutical manufacturing capabilities.
    • Rest Of Europe is expected to maintain consistent market expansion through 2030 driven by innovation in capsule formulations and applications.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    Rest Of Europe Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    Target Audience

    • Pharmaceutical Manufacturers : Manufacturers operating in Rest Of Europe require detailed market data to optimize capsule procurement strategies, forecast demand across therapeutic segments, and identify growth opportunities within their regional operations.
    • Capsule Suppliers & Producers : Capsule manufacturers need region-specific market intelligence to assess demand trends, competitive positioning, and expansion opportunities within Rest Of Europe's pharmaceutical and nutraceutical sectors.
    • Contract Manufacturing Organizations : CMOs serving Rest Of Europe's pharmaceutical industry require accurate market forecasts and therapeutic category insights to align production capacity, negotiate supplier contracts, and plan service offerings.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Rest Of Europe's pharmaceutical supply chain need comprehensive market data, growth projections, and competitive analysis to assess investment viability and portfolio positioning.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts covering Rest Of Europe's pharmaceutical sector require detailed market segmentation, CAGR analysis, and regional insights to support client advisory services and market reports.

    Key Companies in the Rest Of Europe Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    Reasons to Buy this Report

    • Regional Market Sizing : Obtain precise market valuation for Rest Of Europe ($132.3M in 2025) with detailed forecasts through 2030, enabling accurate business planning and investment decisions specific to this geographic segment.
    • Competitive Landscape Analysis : Understand the competitive dynamics within Rest Of Europe's pharmaceutical manufacturing base, identifying key players, market share distribution, and strategic opportunities for capsule suppliers and manufacturers.
    • Growth Trajectory Insights : Analyze the 4.2% CAGR performance relative to global trends (5.6%), revealing regional market maturity levels and identifying emerging opportunities in underperforming therapeutic categories and applications.
    • Therapeutic Category Breakdown : Access detailed segmentation across cardiovascular, respiratory, gastrointestinal, and supplement categories specific to Rest Of Europe, enabling targeted product development and market entry strategies.
    • Strategic Market Entry : Leverage region-specific insights on pharmaceutical manufacturing infrastructure, regulatory environment, and demand patterns to develop informed market entry strategies and partnership opportunities in Rest Of Europe.

    Frequently asked questions

    What is the current market size of empty capsules in Rest Of Europe?

    Rest Of Europe's empty capsules market is estimated at $132.3 million in 2025.

    What is the projected market size for Rest Of Europe by 2030?

    Rest Of Europe's empty capsules market is forecast to reach $162.3 million by 2030.

    What is the CAGR for Rest Of Europe's empty capsules market?

    Rest Of Europe's empty capsules market is growing at a compound annual growth rate of 4.2% from 2025 to 2030.

    What factors are driving growth in Rest Of Europe's empty capsules market?

    Rest Of Europe's market growth is driven by increasing pharmaceutical production, rising demand for capsule dosage forms, expanding nutraceutical applications, and strong regulatory support for pharmaceutical innovation.

    How does Rest Of Europe compare to the global empty capsules market?

    Rest Of Europe's 4.2% CAGR is slightly lower than the global CAGR of 5.6%, reflecting regional market maturity and established manufacturing infrastructure.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status